Search Clinical Trials in the European Union

3-6 months
Visits
Phase
Intake methods
Benefits
Drugs
Locations
Clinical Specialty
321-331 of 331 trials

Nirogacestat: Understanding Its Effects in Healthy Men

We are studying how the drug Nirogacestat affects liver enzymes in healthy men. This research may help us understand its safety and how it works in the body.

Fibromatosis3-6 monthsSafety phase (I)DermatologyInternal Medicine

Colonoscopy Prep: Mannitol vs. Plenvu®

We are studying whether mannitol is as effective and acceptable as Plenvu® for bowel preparation before a colonoscopy. This trial aims to ensure patient comfort and safety during the procedure.

Colonoscopy3-6 monthsConfirmation phase (III)≤5 visitsNo PlaceboStandard MedicinesPartially RemoteGastroenterology

Bile Acid Diarrhea: Atorvastatin Treatment Study

We are investigating whether atorvastatin can help reduce bile acid production and improve symptoms in patients with moderate to severe bile acid diarrhea. The study will also look at various health markers and safety.

Bile Acid Diarrhoea3-6 monthsConfirmation phase (III)Monitoring phase (IV)6-10 visitsStandard MedicinesCost ReimbursementGastroenterology

MK-4082: A Study in Healthy Volunteers

We are testing a new medication called MK-4082 in healthy individuals. This study aims to understand its safety and how it works in the body.

Weight Management3-6 monthsSafety phase (I)EndocrinologyInternal Medicine

Skin Immune Response: SYX-5219 Treatment

We are investigating how SYX-5219 affects immune responses in the skin. This study aims to understand its potential benefits for skin-related conditions.

Atopic Dermatitis3-6 monthsSafety phase (I)Dermatology

ACD856: Safety Study in Healthy Volunteers

We are testing a new medication called ACD856 to see how safe it is and how it affects the body. This study involves healthy participants to help us understand its effects better.

DepressionCognitive DysfunctionAlzheimer’s Disease3-6 monthsSafety phase (I)NeurologyPsychiatry

Cenerimod: Bioavailability Study in Healthy Men

We are evaluating how well the body absorbs cenerimod in healthy male participants. This study aims to gather important information for future treatments.

Healthy Participants3-6 monthsSafety phase (I)

Drug Interaction Study: Carbamazepine and PF-07248144

We are investigating how multiple doses of Carbamazepine affect the way the body processes another medication, PF-07248144. This study aims to improve our understanding of drug interactions.

Locally Advanced or Metastatic ER+/HER2- Breast Cancer3-6 monthsSafety phase (I)Internal MedicineOncology

O3R-5671-PRO: Tolerance Study in Healthy Adults

We are evaluating how well healthy adults tolerate single and multiple doses of the new medication O3R-5671-PRO. This study aims to ensure the safety of the drug for future use.

Inflammatory Bowel DiseasePsoriasis3-6 monthsSafety phase (I)DermatologyInfectious DiseasesInternal Medicine

Type 1 Diabetes: GZR33 Insulin Study

We are evaluating a new insulin called GZR33 to see how it compares to insulin Degludec in managing Type 1 Diabetes. The study focuses on its effectiveness, safety, and how the body processes it.

Type 1 Diabetes3-6 monthsSafety phase (I)DiabetologyEndocrinology

MK-6050: Study in Healthy Volunteers

We are investigating the effects of MK-6050 in healthy individuals. This research aims to gather important safety information about the medication.

Hidradenitis Suppurativa3-6 monthsSafety phase (I)AllergologyDermatology